New Cutoffs for the Biochemical Diagnosis of Adrenal Insufficiency after ACTH Stimulation using Specific Cortisol Assays
Open accessThe DOI matches its Crossref record; 37 of the 39 references it cites were found in a registry or an index; 9 of the 54 sources its claims cite were checked for support.
Abstract
Context: The normal cortisol response 30 or 60 minutes after cosyntropin (ACTH[1–24]) is considered to be ≥18 μg/dL (500 nmol/L). This threshold is based on older serum cortisol assays. Specific monoclonal antibody immunoassays or LC-MS/MS may have lower thresholds for a normal response. Objective: To calculate serum cortisol cutoff values for adrenocorticotropic hormone (ACTH) stimulation testing with newer specific cortisol assays. Methods: Retrospective analysis of ACTH stimulation tests performed in ambulatory and hospitalized patients suspected of adrenal insufficiency (AI). Serum samples were assayed for cortisol in parallel using Elecsys I and Elecsys II immunoassays, and when volume was available, by Access immunoassay and LC-MS/MS. Results: A total of 110 patients were evaluated. Using 18 μg/dL as the cortisol cutoff after ACTH stimulation, 14.5%, 29%, 22.4%, and 32% of patients had a biochemical diagnosis of AI using the Elecsys I, Elecsys II, Access, and LC-MS/MS assays, respectively. Deming regressions of serum cortisol were used to calculate new cortisol cutoffs based on the Elecsys I cutoff of 18 μg/dL. For 30-minute values, new cutoffs were 14.6 μg/dL for Elecsys II, 14.8 μg/dL for Access, and 14.5 μg/dL for LC-MS/MS. Baseline cortisol <2 μg/dL was predictive of subnormal stimulated cortisol values. Conclusion: To reduce false positive ACTH stimulation testing, we recommend a new serum cortisol cutoff of 14 to 15 μg/dL depending on the assay used (instead of the historical value of 18 μg/dL with older polyclonal antibody assays). Clinicians should be aware of the new cutoffs for the assays available to them when evaluating patients for AI.
Overview
CoChat Summary
TL;DR
In 110 patients suspected of adrenal insufficiency, newer specific cortisol assays gave lower ACTH-stimulated cortisol values than the older Elecsys I polyclonal assay, so the historical 18 μg/dL cutoff produced more biochemical AI diagnoses. The authors recommend assay-specific post-cosyntropin cutoffs of 14 to 15 μg/dL to reduce false-positive ACTH stimulation tests.
Key findings
- Using the historical 18 μg/dL cutoff, biochemical AI was diagnosed in 14.5% with Elecsys I, 29% with Elecsys II, 22.4% with Access, and 32% with LC-MS/MS.
- Deming regression from the Elecsys I 18 μg/dL cutoff yielded 30-minute cutoffs of 14.6 μg/dL for Elecsys II, 14.8 μg/dL for Access, and 14.5 μg/dL for LC-MS/MS; 60-minute cutoffs were 14.7, 14.5, and 13.7 μg/dL, respectively.
- Baseline cortisol <2 μg/dL was predictive of subnormal stimulated cortisol values, while values between 2 and 8 μg/dL overlapped substantially between normal and subnormal responders.
- Discordant CST results occurred in 8 of 110 patients (7.3%) across assays using new cutoffs; most abnormal values were close to the cutoff, and clinical review identified secondary AI in 3 of these 8.
Methods
- Retrospective analysis of residual serum samples from 110 ambulatory and hospitalized patients undergoing cosyntropin stimulation testing for suspected adrenal insufficiency from January 8, 2017 to April 30, 2017.
- Cosyntropin (250 mcg ACTH[1–24]) was given intravenously, with serum cortisol measured before injection and at 30 minutes; 60-minute samples were analyzed when ordered. Samples were run in parallel on Elecsys I and Elecsys II, and when volume allowed, on Beckman Access and LC-MS/MS.
- Deming regression was used to calculate new cutoffs from Elecsys I, with Bland-Altman bias analysis, ROC analysis, repeated-measures ANOVA, Mann-Whitney, and chi-square tests.
Limitations
- The paper states there was no independent endocrine test to determine whether patients truly had AI, and many patients lacked long-term follow-up to confirm chronic AI or sustained glucocorticoid need.
- The paper states the cohort came from diverse clinical settings and did not include a healthy subject cohort, though prior healthy-subject studies using specific assays found similar lower thresholds.
- The paper notes CST interpretation is limited without pre-test probability and may be affected by serum protein levels, concurrent medications, and proper timely execution; evident from the text, this was a retrospective single-protocol study using residual samples, with some assays having smaller sample numbers because of insufficient serum volume.
Model-written summary. Check it against the paper before relying on it.
Integrity signals
Registry
Cites
Statistics
Figures




Verification
Claims the paper makes
5 Valid · 3 Not valid · 16 Not checked · 62 Own results and interpretations
At least one cited source doesn’t support this claim or points to a different paper, and none confirmed it — see the verdicts below.
In the paper
“Newer, more-specific cortisol assays with lower cross-reactivity to other endogenous steroids have replaced older, less-specific assays [8, 13, 15, 26, 27].”
§ New Cutoffs for the Biochemical Diagnosis of Adrenal Insufficiency after ACTH Stimulation using Specific Cortisol Assays > Discussion
What the sources say
- Not checked — no full text of the sourcecites [8] Kline GA, Buse J, Krause RD. Clinical implications for biochemical diagnostic thresholds of adrenal sufficiency using a highly specific cortisol immunoassay. Clin Biochem. 2017; 50(9): 475- 480. 28192125 source
- Not checked — no full text of the sourcecites [13] Raverot V, Richet C, Morel Y, Raverot G, Borson-Chazot F. Establishment of revised diagnostic cut-offs for adrenal laboratory investigation using the new Roche Diagnostics Elecsys® Cortisol II assay. Ann Endocrinol (Paris). 2016; 77(5): 620- 622. 27449530 source
- Disputedcites [15] Vogeser M, Kratzsch J, Ju Bae Y, et al. Multicenter performance evaluation of a second generation cortisol assay. Clin Chem Lab Med. 2017; 55(6): 826- 835. 27898397 sourceExperimental — accuracy not yet measured
The Introduction (p. 2) says the second-generation assay was developed to improve specificity. But Table 2 (p. 4) reports greater cross-reactivity with cortisone, an endogenous steroid, for Cortisol II than for the first-generation assay (6.58% versus 0.30%). The paper also describes development and comparison of the two assays, not a general replacement of older assays. (LLM, conf=0.86)
Checked by a reasoning model — may be wrong.
- Not checked — no full text of the sourcecites [26] Ueland GA, Methlie P, Oksnes M, et al. The short cosyntropin test revisited: new normal reference range using LC-MS/MS. J Clin Endocrinol Metab. 2018;103(4):1696-1703. 29452421 source
- Not checked — no full text of the sourcecites [27] El-Farhan N, Pickett A, Ducroq D, et al. Method-specific serum cortisol responses to the adrenocorticotrophin test: comparison of gas chromatography-mass spectrometry and five automated immunoassays. Clin Endocrinol (Oxf). 2013; 78(5): 673- 680. 22994849 source
plainstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
The sources with a verdict support this claim; the rest weren’t checked yet, have no full text we could read, or their verdicts aren’t rated yet.
In the paper
“Serum cortisol concentrations are approximately 20% lower with the newer assays compared with the older assays in some studies [8, 13, 15, 26, 27].”
§ New Cutoffs for the Biochemical Diagnosis of Adrenal Insufficiency after ACTH Stimulation using Specific Cortisol Assays > Abstract > Conclusion
What the sources say
- Not checked — no full text of the sourcecites [8] Kline GA, Buse J, Krause RD. Clinical implications for biochemical diagnostic thresholds of adrenal sufficiency using a highly specific cortisol immunoassay. Clin Biochem. 2017; 50(9): 475- 480. 28192125 source
- Not checked — no full text of the sourcecites [13] Raverot V, Richet C, Morel Y, Raverot G, Borson-Chazot F. Establishment of revised diagnostic cut-offs for adrenal laboratory investigation using the new Roche Diagnostics Elecsys® Cortisol II assay. Ann Endocrinol (Paris). 2016; 77(5): 620- 622. 27449530 source
- Supportedcites [15] Vogeser M, Kratzsch J, Ju Bae Y, et al. Multicenter performance evaluation of a second generation cortisol assay. Clin Chem Lab Med. 2017; 55(6): 826- 835. 27898397 source
The Method comparisons section (p. 5) reports that, for 541 serum samples, the second-generation Cortisol II assay had a slope of 0.76 and an intercept of 10.3 nmol/L relative to the first-generation assay. Those results support approximately 20% lower readings with the newer assay, though the percentage difference varies with concentration. (LLM, conf=0.90)
- Not checked — no full text of the sourcecites [26] Ueland GA, Methlie P, Oksnes M, et al. The short cosyntropin test revisited: new normal reference range using LC-MS/MS. J Clin Endocrinol Metab. 2018;103(4):1696-1703. 29452421 source
- Not checked — no full text of the sourcecites [27] El-Farhan N, Pickett A, Ducroq D, et al. Method-specific serum cortisol responses to the adrenocorticotrophin test: comparison of gas chromatography-mass spectrometry and five automated immunoassays. Clin Endocrinol (Oxf). 2013; 78(5): 673- 680. 22994849 source
hedgedstates an association- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
Every source the paper cites for this claim was checked and supports it.
In the paper
“Grassi et al also found lower cortisol cutoff values of 12.7 and 13.3 μg/dL using Elecsys II and LC-MS/MS assays, respectively [37].”
§ New Cutoffs for the Biochemical Diagnosis of Adrenal Insufficiency after ACTH Stimulation using Specific Cortisol Assays > Discussion
What the sources say
- Supportedcites [37] Grassi G, Morelli V, Ceriotti F, et al. Minding the gap between cortisol levels measured with second-generation assays and current diagnostic thresholds for the diagnosis of adrenal insufficiency: a single-center experience. Hormones (Athens). 2020; 19(3): 425- 431. 32222957 PMC7426310 source
The Discussion reports that the 500 nmol/L threshold corresponded to 351 nmol/L (12.7 μg/dL) with R2 and 368 nmol/L (13.3 μg/dL) with LC-MS/MS. The Assays section identifies R2 as Elecsys Cortisol II, matching the assays and values in the claim. (LLM, conf=0.95)
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Supported
The cited sources that could be checked couldn’t confirm or dispute this claim.
In the paper
“As expected, the 60-minute post-ACTH cortisol was higher than the 30-minute cortisol on each of the cortisol assays evaluated [26, 28, 38].”
§ New Cutoffs for the Biochemical Diagnosis of Adrenal Insufficiency after ACTH Stimulation using Specific Cortisol Assays > Discussion
What the sources say
- Not checked — no full text of the sourcecites [26] Ueland GA, Methlie P, Oksnes M, et al. The short cosyntropin test revisited: new normal reference range using LC-MS/MS. J Clin Endocrinol Metab. 2018;103(4):1696-1703. 29452421 source
- Not checked — no full text of the sourcecites [28] Burt MG, Mangelsdorf BL, Rogers A, et al. Free and total plasma cortisol measured by immunoassay and mass spectrometry following ACTH1–24 stimulation in the assessment of pituitary patients. J Clin Endocrinol Metab. 2013; 98(5): 1883- 1890. 23539724 source
- Could not verifycites [38] Beuschlein F, Fassnacht M, Assié G, et al. Constitutive activation of PKA catalytic subunit in adrenal Cushing’s syndrome. N Engl J Med. 2014; 370(11): 1019- 1028. 24571724 PMC4727447 sourceExperimental — accuracy not yet measured
The Methods section on study patients describes biochemical criteria for corticotropin-independent Cushing’s syndrome, not an ACTH stimulation test comparing cortisol at 30 and 60 minutes. Searches for the quoted comparison and for ACTH stimulation with 30- and 60-minute cortisol assays found no passage addressing it in our copy. (LLM, conf=0.75)
plainstates an association- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“On chart review, 3 of these 8 patients were clinically thought to have secondary AI.”
§ New Cutoffs for the Biochemical Diagnosis of Adrenal Insufficiency after ACTH Stimulation using Specific Cortisol Assays > Results
plainn = 8- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
53 more claims
Create a free account to see all 86 claims and every source verdict.
- Probably not a substantial claim. 16
- It may state two separate claims as one. 12
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“The proposed cutoffs may be applicable to other LC-MS/MS methods after validation but may differ for immunoassays (43, 44).”
From Salivary Cortisol and Cortisone Can Circumvent Confounding Effects of Oral Contraceptives in the Short Synacthen Test (2024) · cites this paper as [44]
Experimental — accuracy not yet measuredIn the citing paper
“The current diagnostic strategy for adrenal insufficiency is for patients to be referred for an ACTH stimulation test, using a cutoff to confirm (<15.6 mg/dl [430 nmol/l]) or exclude (15.6 mg/dl [430 nmol/l]) adrenal insufficiency.”
From Home waking salivary cortisone to screen for adrenal insufficiency (2023) · cites this paper as [26]
In the citing paper
“In the current study, adrenal insufficiency was defined as a peak cortisol level of <15.6 mg/dl (<430 nmol/l) measured by immunoassay.”
From Home waking salivary cortisone to screen for adrenal insufficiency (2023) · cites this paper as [26]
In the citing paper
“The new tools available to detect cortisol are the immunoassays utilizing monoclonal antibodies, such as Elecsys Cortisol generation II and Beckman Access Cortisol, and the Liquid chromatography–tandem mass spectrometry (LC-MS/MS), which is a non-antibody structural assay highly specific for cortisol [41,42,43,44].”
From ACTH Stimulation Test for the Diagnosis of Secondary Adrenal Insufficiency: Light and Shadow (2023) · cites this paper as [44]
In the citing paper
“Over the last years, newer-generation assays with greater specificity for cortisol have been developed and have replaced the old assays in almost all the centers.”
From ACTH Stimulation Test for the Diagnosis of Secondary Adrenal Insufficiency: Light and Shadow (2023) · cites this paper as [44]
Citations
Cites
Bornstein, S. R., Allolio, B., Arlt, W., Barthel, A., Don-Wauchope, A., Hammer, G. D., Husebye, E. S., Merke, D. P., Murad, M. H., Stratakis, C. A., et al. (2016) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2015-1710 · Cited by 1,769 · cited 3×
“Patients with primary AI always have an elevated plasma ACTH, so CST is typically not needed for confirmation of the diagnosis [5, 6].”
BackgroundMarik, P. E., Pastores, S. M., Annane, D., Meduri, G. U., Sprung, C. L., Arlt, W., Keh, D., Briegel, J., Beishuizen, A., Dimopoulou, I., et al. (2008) · Critical Care Medicine · doi:10.1097/ccm.0b013e31817603ba · Cited by 912
Oelkers, W. (1996) · New England Journal of Medicine · doi:10.1056/nejm199610173351607 · Cited by 737 · cited 2×
“As with any endocrine test, no absolute cortisol cutoff for the ACTH stimulation test is perfect for the diagnosis of AI [4, 7, 11, 12].”
BackgroundCharmandari, E., Nicolaides, N. C., & Chrousos, G. P. (2014) · The Lancet · doi:10.1016/s0140-6736(13)61684-0 · Cited by 644
Constitutive activation of PKA catalytic subunit in adrenal Cushing’s syndrome
Beuschlein, F., Fassnacht, M., Assié, G., Calebiro, D., Stratakis, C. A., Osswald, A., Ronchi, C. L., Wieland, T., Sbiera, S., Faucz, F. R., et al. (2014) · New England Journal of Medicine · doi:10.1056/nejmoa1310359 · Cited by 443 · cited 1×
“As expected, the 60-minute post-ACTH cortisol was higher than the 30-minute cortisol on each of the cortisol assays evaluated [26, 28, 38].”
Clinical review 62: Laboratory assessment of adrenal insufficiency.
Grinspoon, S. K., & Biller, B. M. (1994) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.79.4.7962298 · Cited by 442 · cited 6×
“Historically, immunoassays using polyclonal antibodies have been used to establish post-cosyntropin cortisol cutoff concentrations as high as 20 μg/dL [11, 12].”
BackgroundMethodInfluentialHusebye, E. S., Allolio, B., Arlt, W., Badenhoop, K., Bensing, S., Betterle, C., Falorni, A., Gan, E. H., Hulting, A. ‐., Kasperlik‐Zaluska, A., et al. (2014) · Journal of Internal Medicine · doi:10.1111/joim.12162 · Cited by 403 · cited 1×
“Patients with primary AI always have an elevated plasma ACTH, so CST is typically not needed for confirmation of the diagnosis [5, 6].”
BackgroundValue of basal plasma cortisol assays in the assessment of pituitary-adrenal insufficiency
HÄGG, E., ASPLUND, K., & LITHNER, F. (1987) · Clinical Endocrinology · doi:10.1111/j.1365-2265.1987.tb00780.x · Cited by 233 · cited 2×
“Basal morning serum cortisol concentrations are also used to either increase the suspicion for, or rule-out the diagnosis of AI [11, 12, 17-20].”
BackgroundMethodRapid adrenocorticotropic hormone test in practice. Retrospective review
May, M. E., & Carey, R. M. (1985) · The American Journal of Medicine · doi:10.1016/0002-9343(85)90517-0 · Cited by 174 · cited 3×
“Basal morning serum cortisol concentrations are also used to either increase the suspicion for, or rule-out the diagnosis of AI [11, 12, 17-20].”
BackgroundMethodThe approach to the adult with newly diagnosed adrenal insufficiency
Arlt, W. (2009) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2009-0032 · Cited by 165 · cited 1×
“Historically, a cortisol level at 30 or 60 minutes of >18 μg/ dL has been considered normal [5, 9, 10, 35, 36].”
Background
Cited by
Fleseriu, M., Christ‐Crain, M., Langlois, F., Gadelha, M. R., & Melmed, S. K. (2024) · The Lancet · doi:10.1016/s0140-6736(24)00342-8 · Cited by 142
Nieman, L. K., Castinetti, F., Newell-Price, J. D. C., Valassi, E., Drouin, J., Takahashi, Y., & Lacroix, A. (2025) · Nature Reviews Disease Primers · doi:10.1038/s41572-024-00588-w · Cited by 90
“…assays a basal morning serum cortisol of about 10.5 µg/dl (300 nmol/l) indicates an intact axis 192 , and cortrosyn-stimulated values of 13.2–15.7 µg/dl (364–433 nmol/l) at 30 min or 14.6–17.9 µg/dl (403–494 nmol/l) at 60 min suggest that glucocorticoid replacement can be discontinued 192–195 .”
InfluentialHome waking salivary cortisone to screen for adrenal insufficiency
Debono, M., Elder, C. J., Lewis, J., Fearnside, J., Caunt, S., Dixon, S., Jacques, R. M., Newell-Price, J., Whitaker, M. J., Keevil, B., et al. (2023) · NEJM Evidence · doi:10.1056/evidoa2200182 · Cited by 66
Kumar, R., & Wassif, W. (2022) · Journal of Clinical Pathology · doi:10.1136/jclinpath-2021-207895 · Cited by 69
Cortisol: Biosensing and detection strategies
Balasamy, S., Atchudan, R., Arya, S. K., Gunasekaran, B. M., Nesakumar, N., & Sundramoorthy, A. K. (2024) · Clinica Chimica Acta · doi:10.1016/j.cca.2024.119888 · Cited by 53
Yuen, K. C. J., Samson, S. L., Bancos, I., Gosmanov, A. R., Jasim, S., Fecher, L. A., & Weber, J. S. (2022) · Endocrine Practice · doi:10.1016/j.eprac.2022.04.010 · Cited by 46
DeLozier, O. M., Dream, S. Y., Findling, J. W., Carroll, T. B., Evans, D. B., & Wang, T. S. (2021) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgab698 · Cited by 42
Self-citationSecondary Adrenal Insufficiency: Recent Updates and New Directions for Diagnosis and Management
Gruber, L., & Bancos, I. (2021) · Endocrine Practice · doi:10.1016/j.eprac.2021.09.011 · Cited by 45
From liver to hormones: The endocrine consequences of cirrhosis
Aldave, J. E. Q., Osorio, E. R. G., Durand‐Vásquez, M. D. C., Rafael-Robles, L. D. P., Yovera, J. G. G., Quispe-Flores, M. A., Urteaga, L. A. C., Román-Gonzaléz, A., Paz‐Ibarra, J., & Concepción‐Zavaleta, M. J. (2024) · World Journal of Gastroenterology · doi:10.3748/wjg.v30.i9.1073 · Cited by 45
“Despite the lack of a consensus, the presence of adrenal insufficiency should be evaluated in patients with refractory hypotension, patients with sodium levels less than 125 mmol/L, and patients with HDL levels less than 0.39 mmol/L (15 mg/dL)[85,88-90].”
InfluentialPituitary Incidentalomas: Best Practices and Looking Ahead
Giraldi, E. A., Allen, J. W., & Ioachimescu, A. G. (2022) · Endocrine Practice · doi:10.1016/j.eprac.2022.10.004 · Cited by 42
A Comprehensive Review of Empty Sella and Empty Sella Syndrome
Lundholm, M. D., & Yogi-Morren, D. (2024) · Endocrine Practice · doi:10.1016/j.eprac.2024.03.004 · Cited by 34
Current Challenges and Future Directions in the Assessment of Glucocorticoid Status
Clarke, S. A., Eng, P. C., Comninos, A. N., Lazarus, K., Choudhury, S., Tsang, C., Meeran, K. M., Tan, T., Dhillo, W. S., & Abbara, A. (2024) · Endocrine Reviews · doi:10.1210/endrev/bnae016 · Cited by 38
Izuchi, T., Iwama, S., Yamagami, A., Kobayashi, T., Suzuki, K., Murase, T., Ando, M., Murasawa, S., Mukai, K., Takagi, H., et al. (2026) · Frontiers in Endocrinology · doi:10.3389/fendo.2026.1741709 · Cited by 213
Zha, L., Li, J., Krishnan, S. M., Brennan, M. R., Zhang, Y. V., Povse, P., Kerlin, R., Shively, K., Oleksik, F., Williams, J., et al. (2022) · Endocrine Practice · doi:10.1016/j.eprac.2022.04.003 · Cited by 34
Perioperative evaluation and management of patients on glucocorticoids
Chen Cardenas, S. M., Santhanam, P., Morris-Wiseman, L., Salvatori, R., & Hamrahian, A. H. (2022) · Journal of the Endocrine Society · doi:10.1210/jendso/bvac185 · Cited by 31
Adrenal Insufficiency in Cirrhosis
Wentworth, B. J., & Siragy, H. M. (2022) · Journal of the Endocrine Society · doi:10.1210/jendso/bvac115 · Cited by 33
“Given this significant variation, a new baseline TC threshold of <55 nmol/L or a peak TC between 386 and 414 nmol/L to define AI has been proposed in the general population when using newer generation immunoassays or LC-MS [47]; formal adoption remains pending.”
BackgroundMethodInfluentialApproach to the Patient With Immune Checkpoint Inhibitor–Associated Endocrine Dysfunction
Wright, J. J., & Johnson, D. B. (2022) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgac689 · Cited by 34
Recognition of Nonneoplastic Hypercortisolism in the Evaluation of Patients With Cushing Syndrome
Findling, J. W., & Raff, H. (2023) · Journal of the Endocrine Society · doi:10.1210/jendso/bvad087 · Cited by 31
Self-citationGlucocorticoid treatment and adrenal suppression in children: current view and open issues
Improda, N., Chioma, L., Capalbo, D., Bizzarri, C., & Salerno, M. (2024) · Journal of Endocrinological Investigation · doi:10.1007/s40618-024-02461-9 · Cited by 35
Husni, H., Abusamaan, M. S., Dinparastisaleh, R., Sokoll, L., Salvatori, R., & Hamrahian, A. H. (2022) · Frontiers in Endocrinology · doi:10.3389/fendo.2022.978238 · Cited by 26
“enrolled 110 patients undergoing standarddose CST using the Elecsys Cortisol I, Elecsys Cortisol II, Beckman Coulter Access, and LC-MS/MS assays (6).”
MethodOpioids and pituitary function: expert opinion
Gadelha, M. R., Karavitaki, N., Fudin, J., Bettinger, J. J., Raff, H., & Ben-Shlomo, A. (2022) · Pituitary · doi:10.1007/s11102-021-01202-y · Cited by 27
“As the cortisol competitive binding immunoenzymatic assay used in this study was recently demonstrated to show lower cortisol values and therefore a lower cortisol threshold on ACTH1–24-stimulation test of ~ 14–15 μg/ dL (384–414 nmol/L) [76], some included patients may not have actually had adrenal insufficiency.”
BackgroundMethodSelf-citationOkutan, S., Jørgensen, N. T., Pedersen, L. E., Borresen, S. W., Hilsted, L. M., Friis-Hansen, L. J., Feldt‐Rasmussen, U., & Klose, M. (2024) · Endocrine · doi:10.1007/s12020-024-03752-0 · Cited by 28
“…recent years, studies have tested different 2nd generation cortisol immunoassays using more speci fi c antibodies and suggested cortisol cut-off limits for the ACTH test ranging from 350 – 460 nmol/L [12 – 18], which is lower than the formerly recommended cut-off limit at 500 – 550 nmol/L [19].”
InfluentialLatent Adrenal Insufficiency: From Concept to Diagnosis
Younès, N., Bourdeau, I., & Lacroix, A. (2021) · Frontiers in Endocrinology · doi:10.3389/fendo.2021.720769 · Cited by 27
Yuen, K. C. J. (2021) · Endocrine Practice · doi:10.1016/j.eprac.2021.06.012 · Cited by 27
A Contemporary Approach to the Diagnosis and Management of Adrenal Insufficiency
Charoensri, S., & Auchus, R. J. (2024) · Endocrinology and Metabolism · doi:10.3803/enm.2024.1894 · Cited by 28
“…in patients suspected of AI recommended that threshold 30-minute post-stimulation cortisol values of 14.6 µg/dL for Elecsys II (Roche Diagnostics GmbH, Mannheim, Germany) and 14.8 µg/ dL for Access platform immunoassays (Beckman Coulter, Inc., Brea, CA, USA), to reduce false positives [20].”
InfluentialACTH Stimulation Test for the Diagnosis of Secondary Adrenal Insufficiency: Light and Shadow
Birtolo, M. F., Antonini, S., Saladino, A., Zampetti, B., Lavezzi, E., Chiodini, I., Mazziotti, G., Lania, A. G. A., & Cozzi, R. (2023) · Biomedicines · doi:10.3390/biomedicines11030904 · Cited by 19
Ahmet, A. H., Tobin, R., Dang, U. J., Rooman, R., Guglieri, M., Clemens, P. R., Hoffman, E. P., & Ward, L. M. (2024) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgae521 · Cited by 23
An update on the diagnosis and treatment of adrenoleukodystrophy
Gujral, J., & Sethuram, S. (2022) · Current Opinion in Endocrinology Diabetes and Obesity · doi:10.1097/med.0000000000000782 · Cited by 21
“Normal stimulated cortisol values measured with newer, sensitive assays are now recognized to be equal to or greater than 14-15mcg/dL at 1 hour compared with the previous cut-off of at least 18mcg/dL [31].”
BackgroundAn impaired pituitary–adrenal signalling axis in stable cirrhosis is linked to worse prognosis
Hartl, L., Simbrunner, B., Jachs, M., Wolf, P. S., Bauer, D. J. M., Scheiner, B., Balcar, L., Semmler, G., Schwarz, M., Marculescu, R., et al. (2023) · JHEP Reports · doi:10.1016/j.jhepr.2023.100789 · Cited by 21
Han, A. J., Suresh, M., Gruber, L., Algeciras‐Schimnich, A., Achenbach, S. J., Atkinson, E. J., & Bancos, I. (2024) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgae855 · Cited by 18
Self-citationParksook, W. W., Heydarpour, M., Gholami, K., Luther, J. M., Hopkins, P. N., Pojoga, L. H., & Williams, J. S. (2022) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgac011 · Cited by 16
Bitencourt, M. R., Batista, R. L., Biscotto, I. P., & Carvalho, L. R. S. (2022) · Archives of Endocrinology and Metabolism · doi:10.20945/2359-3997000000493 · Cited by 16
“A recent study using current laboratory assays (LC-MS and monoclonal antibody) described a baseline cortisol level of 55 nmol/L (2 μg/dL) related to an inadequate pituitary response to stimulus tests (31).”
BackgroundMethodInfluentialBäcklund, N., Lundstedt, S., Tornevi, A., Wihlbäck, A.-C., Olsson, T., Dahlqvist, P., & Brattsand, G. (2024) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgad763 · Cited by 13
“The proposed cutoffs may be applicable to other LC-MS/MS methods after validation but may differ for immunoassays (43, 44).”
MethodZhu, L., Cheung, Y.-M. M., Chiang, C. Y., Gallagher, E. J., Hamnvik, O. R., Mammen, J. S., Quandt, Z., Jones, R., McDunn, J., Al-Bahadili, H., et al. (2025) · Journal for ImmunoTherapy of Cancer · doi:10.1136/jitc-2025-011865 · Cited by 16
“72 To facilitate more efficient diagnosis and treatment, we have proposed cut-offs for consideration of ICI-related AI as morning cortisol level of 5 mcg/dL (138 nmol/L), or between 5 and 13 mcg/ dL (138–359 nmol/L) with suboptimal response to cosyn-tropin stimulation.”
Adrenal insufficiency in patients with Prader-Willi syndrome
Kusz, M., & Gawlik, A. (2022) · Frontiers in Endocrinology · doi:10.3389/fendo.2022.1021704 · Cited by 13
“At present, however, there are no TABLE 2 All stimulation tests used to diagnose central adrenal insufficiency in children (6, 22).”
BackgroundRamadoss, V., Lazarus, K., Prevost, A. T., Tan, T., Meeran, K. M., & Choudhury, S. (2021) · Journal of the Endocrine Society · doi:10.1210/jendso/bvab147 · Cited by 12
“This is slightly higher than the suggested lower limit of 403 nmol/L for the newer generation of Roche analyzers [26].”
BackgroundHerodes, M., Le, N., Anderson, L. J., Migula, D., Miranda, G., Paulsen, L., & Garcia, J. M. (2023) · Growth Hormone & IGF Research · doi:10.1016/j.ghir.2023.101544 · Cited by 12
Opioid-induced adrenal insufficiency: diagnostic and management considerations
Patel, E., & Ben-Shlomo, A. (2024) · Frontiers in Endocrinology · doi:10.3389/fendo.2023.1280603 · Cited by 13
Rotolo, L., Galante, G., Coscia, K., Bissi, V., Tucci, L., Mezzullo, M., Gambineri, A., Vicennati, V., Zavatta, G., Pagotto, U., et al. (2025) · European Journal of Endocrinology · doi:10.1093/ejendo/lvaf141 · Cited by 12
Early Detection of Adrenal Insufficiency: The Impact of Newborn Screening for Adrenoleukodystrophy
Alcantara, J. R., Grant, N. R., Sethuram, S., Nagy, A. M., Becker, C., Sahai, I., Stanley, T. L., Halper, A., & Eichler, F. (2023) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgad286 · Cited by 12
Approach to the Patient: From Endocrinopathy to the Diagnosis of a Histiocytic Disorder
Makras, P., Erickson, D. Z., Davidge-Pitts, C. J., Diamond, E. L., Allen, C. E., McClain, K. L., Abeykoon, J. P., Go, R. S., Siwakoti, K., Sotoudeh, H., et al. (2024) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgae827 · Cited by 12
Cortez, S., Arbeláez, A. M., Wallendorf, M., & McNerney, K. P. (2023) · Journal of Clinical Research in Pediatric Endocrinology · doi:10.4274/jcrpe.galenos.2023.2023-2-3 · Cited by 11
“Previous studies in adults (10,11,12), report conflicting results when establishing a new cutoff level for the biochemical diagnosis of AI.”
BackgroundResultMonitoring for and Management of Endocrine Dysfunction in Adrenoleukodystrophy
Kachwala, I. A., & Regelmann, M. O. (2022) · International Journal of Neonatal Screening · doi:10.3390/ijns8010018 · Cited by 14
“Since that time, th re ave been significant changes to many cortisol assays, and it has been proposed that cosyntropin stimulated cortisol cutoffs of 14 to 15 μg/dL for monoclonal cortisol antibody immunoassays and LC-MS/MS would reduce false-positive test results [34].”
BackgroundColling, C., Nachtigall, L., Biller, B. M. K., & Miller, K. K. (2022) · Clinical Endocrinology · doi:10.1111/cen.14587 · Cited by 9
The existence of adrenal insufficiency in patients with COVID-19 pneumonia
Porntharukchareon, T., Dechates, B., Sirisreetreerux, S., Therawit, P., & Tawinprai, K. (2024) · Frontiers in Endocrinology · doi:10.3389/fendo.2024.1337652 · Cited by 8
Hamidi, O., Salama, B., Wang, T. S., Findling, J. W., Zhang, C. D., Carroll, T. B., Dream, S. Y., Sada, A., Balderrama-Brondani, V., Dogra, P., et al. (2025) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgaf515 · Cited by 12
“We acknowledge that using this cutoff, as opposed to the proposed lower CST cortisol cutoffs (27), may have resulted in overdiagnosis of adrenal insufficiency.”
Self-citation46,XX males with congenital adrenal hyperplasia: a clinical and biochemical description
Adriaansen, B. P. H., Utari, A., Westra, D., Juniarto, A. Z., Ariani, M. D., Ediati, A., Schröder, M. A. M., Span, P. N., Sweep, F. C. G. J., Drop, S. L. S., et al. (2024) · Frontiers in Endocrinology · doi:10.3389/fendo.2024.1410122 · Cited by 9
Yoon, J. H., Ahn, S., Jung, S., Lee, J., Choi, W., Park, J. Y., Hong, A. R., Kim, H. K., & Kang, H. (2021) · BioMed Research International · doi:10.1155/2021/2330417 · Cited by 9
“Third, recent studies have suggested new lower serum cortisol cutoff value to reduce overdiagnosis of AI using specific monoclonal antibody immunoassays or liquid chromatography–tandem mass spectrometry methods [30].”
BackgroundHow I Approach It: Adrenal Insufficiency in Cirrhosis
Wentworth, B. J., Henry, Z. H., & Siragy, H. M. (2022) · The American Journal of Gastroenterology · doi:10.14309/ajg.0000000000001939 · Cited by 9
“Historical polyclonal immunoassays cross-react with other steroid hormones, providing less specific and higher measured cortisol levels than newer monoclonal immunoassays or liquid chromatography-tandem mass spectrometry (11).”
BackgroundMorning serum cortisol role in the adrenal insufficiency diagnosis with modern cortisol assays
Perozo, A. F. D. F., Fontes, R., Lopes, F. P., Araújo, P. B., Scrank, Y., Gomes, D. M. V., Moraes, A. B., & Neto, L. V. (2023) · Journal of Endocrinological Investigation · doi:10.1007/s40618-023-02062-y · Cited by 9
“The normal cortisol response to stimulation in either the SST or the ITT was defined based on the cortisol assay [22], in which an adequate response to SST or ITT for Beckman Access Cortisol was a peak cortisol level > 408 nmol/L (14.8 mcg/dL) at any time after stimulus and for Roche Elecsys…”
BackgroundMethodResultInfluentialAtluri, S., Sarathi, V., Goel, A., Shivaprasad, C., Alapaty, S., Dhananjaya, M. S., Barure, R., & Kolla, G. (2022) · Indian Journal of Endocrinology and Metabolism · doi:10.4103/ijem.ijem_461_21 · Cited by 9
Feldt‐Rasmussen, U., & Klose, M. (2025) · Best Practice & Research Clinical Endocrinology & Metabolism · doi:10.1016/j.beem.2025.102020 · Cited by 9
Diagnostic strategies in adrenal insufficiency
Siampanopoulou, V., Tasouli, E., & Angelousi, A. G. (2023) · Current Opinion in Endocrinology Diabetes and Obesity · doi:10.1097/med.0000000000000806 · Cited by 9
Lazarus, K., Hayes, A., Narula, K., Papadopolou, D., Tan, T., Meeran, K. M., & Choudhury, S. (2024) · Clinical Endocrinology · doi:10.1111/cen.15074 · Cited by 8
“24,25”
Klaassen, D., Mok, S., Hwang, J. Y., Blount, S. L., Williams, K. J., Fong, B. M., Chicoine, M. R., Dacey, R. G., Farrell, N. F., Osbun, J. W., et al. (2025) · Neuro-Oncology · doi:10.1093/neuonc/noaf069 · Cited by 9
A New Approach — Home Waking Salivary Cortisone to Screen for Adrenal Insufficiency
Raff, H., & Zhang, C. D. (2023) · NEJM Evidence · doi:10.1056/evide2200306 · Cited by 8
Self-citationSahoo, S. K., Menon, J. C., Tripathy, N., Nayak, M., & Yadav, S. (2024) · Endocrine Connections · doi:10.1530/ec-24-0086 · Cited by 7
“The diagnosis of AI using APST has been previously validated against ITT and SST (17, 18, 19).”
BackgroundInfluentialInsights From Minnesota on Newborn Screening for Adrenoleukodystrophy: A 5‐Year Update
Rayannavar, A., Billington, C. J., Tryon, R. K., Kaye, T. V., Gupta, A. V., Lund, T. C., Lteif, A. N., Adriatico, K. L., Orchard, P. J., Miller, B. S., et al. (2025) · American Journal of Medical Genetics Part A · doi:10.1002/ajmg.a.63995 · Cited by 9
“Based on recent evidence/data on cortisol values derived from Elecsys II immunoassay, we as a group lowered our cortisol cut-off to 15 μg/dL on the ACTH stimulation test within the past few months (Javorsky et al. 2021).”
Hamidi, O., Miljanic, M., Tumyan, G., Christie, A. L., Mirfakhraee, S., Ali, S., Dohopolski, M. J., Gottumukkala, S., Brugarolas, J., Timmerman, R. D., et al. (2024) · Cancers · doi:10.3390/cancers16183140 · Cited by 7
“PAI was diagnosed when early morning serum cortisol concentration was 5 µ g/dL in combination with a plasma adrenocorticotropic hormone (ACTH) quantity greater than 2-fold the upper limit of the reference range [28,29].”
BackgroundMethodInfluentialAutoimmune Primary Adrenal Insufficiency: Understanding the Past, Present, and Future
Surani, A., & Carroll, T. B. (2025) · Endocrine Practice · doi:10.1016/j.eprac.2025.04.008 · Cited by 8
Self-citationBarbar, B., Mathieson, C., Boot, C., Quinton, R., James, A., Perros, P., Pearce, S. H. S., Napier, C., Gan, E. H., Mitchell, A. L., et al. (2023) · Clinical Endocrinology · doi:10.1111/cen.14919 · Cited by 6
The multiple faces of autoimmune Addison’s disease in children
Capalbo, D., Esposito, A. A., Gaeta, V., Lorello, P., Vasaturo, S., Mase, R. D., & Salerno, M. (2024) · Frontiers in Endocrinology · doi:10.3389/fendo.2024.1411774 · Cited by 8
Variations in cortisol response in patients with known and suspected adrenal insufficiency
Mahzari, M. M., AlSohaim, A., Almulla, A. K., AlAssaf, A., Amri, K. A., Hussain, S. D., Sabico, S., Daghri, N. M. A., & Al‐Saleh, Y. (2022) · Medicine · doi:10.1097/md.0000000000032557 · Cited by 6
Diagnosis and management of secondary adrenal crisis
Martel‐Duguech, L., Poirier, J., Bourdeau, I., & Lacroix, A. (2024) · Reviews in Endocrine and Metabolic Disorders · doi:10.1007/s11154-024-09877-x · Cited by 8
Kasahara, A., Kida, T., Hirano, A., Ōmura, S., Sofue, H., Sakashita, A., Sagawa, T., Asano, M., Fukui, M., Wada, M., et al. (2022) · Modern Rheumatology · doi:10.1093/mr/roab091 · Cited by 6
“Insufficient adrenal response was defined as a cortisol level <420 nmol/L 30min after corticotropin injection [31, 32].”
MethodTreating Hypopituitarism in the Over 65s: Review of Clinical Studies
Paragliola, R. M., Locantore, P., Corsello, S. M., & Salvatori, R. (2023) · Clinical Interventions in Aging · doi:10.2147/cia.s370782 · Cited by 6
“It is important to remember that newer, more specific (based on monoclonal antibodies) cortisol assays have results that are significantly (about 30%) lower than older assays.(47,48) Impairment of the HPA axis can cause hyponatremia, because glucocorticoid deficiency can produce altered water excretion.”
BackgroundGoyal, A., Attri, B., Gupta, Y., Kalaivani, M., Jyotsna, V. P., & Tandon, N. (2023) · Clinical Endocrinology · doi:10.1111/cen.14920 · Cited by 6
“Recently, using these newer kits, post‐ACTH stimulation cortisol cut‐offs for diagnosis of adrenal insufficiency were revised to 397 nmol/L (from a historical value of 497 nmol/L).(34) We demonstrated that LNSC measured using Elecsys Cortisol‐II assay was a reliable and accurate measure for the diagnosis of CS, with a…”
MethodPelewicz, K., & Miśkiewicz, P. (2024) · Journal of Endocrinological Investigation · doi:10.1007/s40618-024-02304-7 · Cited by 6
“Javorsky et al. propose a new cortisol cutoff of 14–15 μg/dL in HDT for the diagnosis of AI with newer cortisol assays [36].”
Current Screening Strategies for the Diagnosis of Adrenal Insufficiency in Children
Bowden, S. A. (2023) · Pediatric Health Medicine and Therapeutics · doi:10.2147/phmt.s334576 · Cited by 5
“Therefore, the cortisol cutoff values can be lowered to 14–15 ug/dL (386–413 nmol/L) when using newer assays.(21) When using the classic threshold of cortisol cutoff <18 ug/dL (497 nmol/L) with these newer assays, many more patients would have been given the biochemical diagnosis of AI and may have been treated with h…”
MethodLawrence, N., Arshad, M. F., Pofi, R., Ashby, S., Dawson, J., Tomlinson, J., Newell-Price, J. D. C., Ross, R. J. M., Elder, C. J., & Debono, M. (2023) · Journal of the Endocrine Society · doi:10.1210/jendso/bvad127 · Cited by 5
“…previous AST measured on a different assay from the recent AST measurement, as the relationship between baseline cortisol and 30-minute cortisol on different assays will be different, with cortisol measurements from different assays having been shown to be up to 39% different in magnitude [17].”
MethodMandava, M., Lew, J., Tisdale, J. F., Limerick, E. M., Fitzhugh, C. D., & Hsieh, M. M. (2023) · Journal of the Endocrine Society · doi:10.1210/jendso/bvad134 · Cited by 6
Sharma, E., Berry, J. S., Griffiths, B., Lorenzi, A. R., Thompson, B. T., Boot, C., & Mamoojee, Y. H. (2024) · Clinical Endocrinology · doi:10.1111/cen.15077 · Cited by 5
Effect of Steroid Replacement on Long-Term Kidney Function in Patients With Adrenal Insufficiency
Kim, J. H., Kim, J. Y., Kim, H. W., Han, S. H., Yoo, T., Kang, S., & Park, J. T. (2022) · Endocrine Practice · doi:10.1016/j.eprac.2021.12.015 · Cited by 6
Sanz-Pastor, A. G., Gómez-Gordo, M., Guerra, A. L., & Albarrán, O. G. (2024) · Medicine - Programa de Formación Médica Continuada Acreditado · doi:10.1016/j.med.2024.08.010 · Cited by 4
Pituitary function in patients with primary and secondary empty sella
Steckel, L., Gizewski, E. R., & Kaser, S. (2025) · Frontiers in Endocrinology · doi:10.3389/fendo.2025.1632824 · Cited by 4
“Diagnosis of adrenal insuf fi ciency was excluded with peak cortisol levels ≥ 18 ug/dl (500 nmol/l) (13 – 17).”
Hypophysitis Associated with Immune Checkpoint Inhibitors
Corsello, A., Paragliola, R. M., Torino, F., & Salvatori, R. (2025) · Endocrinology and Metabolism Clinics of North America · doi:10.1016/j.ecl.2025.06.009 · Cited by 4
Shalitin, S. (2024) · Hormone Research in Paediatrics · doi:10.1159/000537969 · Cited by 6
“…threshold of cortisol cutoff > 497 nmol/L (18 μ g/ dL) should be used, and when using the newer highly speci fi c cortisol assays based on monoclonal antibodies or liquid chromatography-tandem mass spectrometry (LC-MS/MS), the cortisol cutoff values can be lowered to 415 nmol/L (15 μ g/dL) [64].”
Carides, M., Mehta, R., Louw, J. C., & Mohamed, F. (2024) · Endocrinology Diabetes and Metabolism Case Reports · doi:10.1530/edm-23-0136 · Cited by 4
Øzdemir, C. M., Nielsen, M. M., Liimatta, J., Voegel, C. D., Elzenaty, R. N., Wasehuus, V. S., Lind‐Holst, M., Ørnstrup, M. J., Gram, S. B., Ousager, L. B., et al. (2024) · Endocrinology Diabetes and Metabolism Case Reports · doi:10.1530/edm-23-0090 · Cited by 5
Varlamov, E. V., & Fleseriu, M. (2022) · Elsevier eBooks · doi:10.1016/b978-0-323-99899-4.00019-6 · Cited by 6
Diagnosing and treating the elderly individual with hypopituitarism
Corsello, A., Paragliola, R. M., & Salvatori, R. (2023) · Reviews in Endocrine and Metabolic Disorders · doi:10.1007/s11154-023-09870-w · Cited by 5
“In the same study, the Authors found that using these more specific assays a basal cortisol level 2 mcg/dL is predictive of sub-normal stimulated cortisol levels [70].”
Research on the stability changes in expert consensus of the ACTH detection preprocessing scheme
Dong, L., Hao, T., Chen, J., Chai, Y., Jia, Z., Tuo, W., Yuan, C., & Luo, W. (2024) · Journal of Laboratory Medicine · doi:10.1515/labmed-2023-0086 · Cited by 4
Clinical Presentation of Congenital Hypopituitarism: Lessons From a Large Academic Centre
Ladd, J. M., Pyle‐Eilola, A. L., Mamilly, L., Chaudhari, M., & Henry, R. K. (2025) · Clinical Endocrinology · doi:10.1111/cen.15213 · Cited by 3
“…was defined as follows: – ACTH Deficiency: Peak cortisol less than 15.5 μ g/dL in response to low dose (1 mcg) cosyntropin stimulation test [14] without administration of glucocorticoids, opioids, or ketoconazole within the preceding 48 h. – TSH Deficiency: Low free T4 for age with…”
InfluentialKlahr, J. D., Carroll, T. B., Nerenz, R. D., & Raff, H. (2025) · AACE Endocrinology and Diabetes · doi:10.1016/j.aed.2025.07.008 · Cited by 3
Self-citationA practical approach to diagnosis and treatment in children with primary adrenal insufficiency
Capalbo, D., Illiano, S., Vasaturo, S., Lorello, P., Rotondo, F. R., Mase, R. D., Bizzarri, C., & Salerno, M. (2025) · European Journal of Endocrinology · doi:10.1093/ejendo/lvaf229 · Cited by 5
Basal cortisol levels do not predict adrenal responsiveness in acute decompensated cirrhosis
Wentworth, B. J., Schliep, M. K., Novicoff, W. M., Henry, Z. H., & Siragy, H. M. (2023) · European Journal of Gastroenterology & Hepatology · doi:10.1097/meg.0000000000002694 · Cited by 3
“Specifically, our findings can accommodate the movement toward lower peak cortisol thresholds to diagnose adrenal insufficiency given newer, more specific commercial cortisol assays [30].”
BackgroundRates of adrenal insufficiency using a monoclonal vs. polyclonal cortisol assay
McNerney, K. P., & Arbeláez, A. M. (2021) · Journal of Pediatric Endocrinology and Metabolism · doi:10.1515/jpem-2021-0519 · Cited by 4
Sarathi, V., Reddy, A., Tirupati, S., & Jumkhawala, K. (2022) · Indian Journal of Clinical Biochemistry · doi:10.1007/s12291-022-01039-7 · Cited by 3
“Hence, these studies recommend lowering the serum cortisol cut-off to * 14 lg/dl when measured by LC–MS/MS to avoid the false diagnosis of adrenal insufficiency [8, 9].”
MethodBoekstegers, A., Schmidt, H., Kurzay, M., Vallée, T. C., Jung, E., Dubinski, I., Maxwell-Stuart, R., & Schmid, I. (2023) · Cancer Medicine · doi:10.1002/cam4.5667 · Cited by 6
Zarzour, F., Hage, M. P., Raffin‐Sanson, M., Baussart, B., & Chakhtoura, M. (2023) · Annales d Endocrinologie · doi:10.1016/j.ando.2023.03.026 · Cited by 3
Alcohol-induced Cushing syndrome: report of eight cases and review of the literature
Surani, A., Carroll, T. B., Javorsky, B. R., Raff, H., & Findling, J. W. (2023) · Frontiers in Endocrinology · doi:10.3389/fendo.2023.1199091 · Cited by 4
Self-citationBirtolo, M. F., Giannini, E., Antonini, S., Lavezzi, E., Lasio, G. B., Rin, G. D., Mazziotti, G., & Lania, A. G. (2024) · Pituitary · doi:10.1007/s11102-023-01368-7 · Cited by 6
“Beckman Access Cortisol® is the routinary assay used in our hospital since 2016 and consequently SAI was made if cortisol peak was below 14.8 µg/dL (408 nmol/L) at 30 or 60 min after ACTH stimulus [26].”
InfluentialHeydarpour, M., Parksook, W. W., Pojoga, L. H., Williams, G. H., & Williams, J. S. (2024) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgae127 · Cited by 4
Impact of systemic treatments for advanced thyroid cancer on the adrenal cortex
Colombo, C., Ceruti, D., Succi, M., Leo, S. D., Trevisan, M., Moneta, C., & Fugazzola, L. (2022) · European Thyroid Journal · doi:10.1530/etj-23-0246 · Cited by 4
“Nevertheless, since cortisol assays have recently become more sensitive and a new cutoff of 15 μg/dL has been proposed (23 , 24 , 25 ), we calculated the prevalence of PAI accordingly.”
MethodTosun, B. G., Turan, S., Haklar, G., Bereket, A., & Güran, T. (2025) · Hormone Research in Paediatrics · doi:10.1159/000544945 · Cited by 2
“These include mAb immunoassays such as Elecsys Cortisol II and Beckman Access Cortisol, as well as the highly speci fi c non-antibody structural assay LC-MS/MS [26, 44, 45].”
InfluentialAch, T., Dhaffar, R., Ammar, A., Ghachem, A., Halloul, I., Saafi, W., Elfekih, H., Saad, G., Hasni, Y., & Zaouali, M. (2025) · Medicina · doi:10.3390/medicina61071303 · Cited by 3
“For example, newer monoclonal immunoassays, like the Elecsys Cortisol Generation II and Beckman Access Cortisol, typically produce cortisol values that are 20–30% lower than older polyclonal assays [21,22].”
Wentworth, B. J., Geng, C. X., Novicoff, W. M., Siragy, H. M., & Henry, Z. H. (2025) · Digestive Diseases and Sciences · doi:10.1007/s10620-025-09237-y · Cited by 2
“Some authors have previously defined AD in cirrhosis by failure to achieve a peak total cortisol level of 18 µg/dL (500 mmol/L) [23], but the 14 µg/dL threshold is consistent with recent literature reporting improved specificity of newer generation cortisol assays [24].”
Adrenal function, morbidity and mortality in patients with COVID-19
Rozenfeld, K., Shemesh, E., Izkhakov, E., Moshiashvili, M., Feigin, E., Goldiner, I., Katz, B., Tordjman, K. M., Shefer, G., & Greenman, Y. (2025) · Endocrine · doi:10.1007/s12020-025-04401-w · Cited by 2
Effects of Lenvatinib treatment for advanced differentiated thyroid cancer on cortisol deficiency
Monti, S., Fazzalari, B., Renzelli, V., Bongermino, C., Lioni, M. F., Deiana, M. G., Poggi, M., Mori, F., & Pugliese, G. (2026) · Frontiers in Endocrinology · doi:10.3389/fendo.2025.1691740 · Cited by 2
Sheikh‐Ahmad, M., Rosenblat, I., Salameh, S., Dakwar, B., Shalata, A., Yosefia, S., Rabani, H., Jovanovic, K., & Saiegh, L. (2026) · BMC Endocrine Disorders · doi:10.1186/s12902-026-02170-9 · Cited by 2
“…a total number of 110 patients, using Cort30 of 14 (386 nmol/L) to 15 µg/dl (414 nmol/L) as an adequate stimulation, MSC threshold of 2 µg/dL (55 nmol/L) was the most reliable predictor of abnormal SST (100% specificity), but other MSC values were not reliable for predicting cortisol response [13].”
Metadata
- Authors
- Javorsky, B. R., Raff, H., Carroll, T. B., Algeciras-Schimnich, A., Singh, R. J., Colón-Franco, J. M., & Findling, J. W.
- Affiliations
- Froedtert Hospital (US)
- Medical College of Wisconsin (US)
- Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN 55905, USA
- Mayo Clinic (US)
- Corresponding author
- Javorsky, Bradley R
- ORCID
- Venue
- Journal of the Endocrine Society
- Publisher
- The Endocrine Society
- Published
- 2021-02-18
- Volume
- 5
- Issue
- 4
- Pages
- bvab022-bvab022
- ISSN
- 2472-1972 (ISSN-L)
- PMC
- PMC7975762
- OpenAlex
- W3132722879
- Semantic Scholar
- d204c31770bedad774ffe4ea48c1fe1f03f7bedd
- Cited by
- 171
- References
- 39
- Citations by year
- 2026: 29 · 2025: 38 · 2024: 37 · 2023: 32 · 2022: 24 · 2021: 11
- FWCI
- 17.85
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- Locations
- Journal of the Endocrine Society (publishedVersion, cc-by-nc-nd)
- PubMed Central (publishedVersion, cc-by-nc-nd)
- PubMed (publishedVersion)
- Funders
- Advocate Aurora Research Institute
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Adrenal Hormones and Disorders
- Health Sciences › Health Professions › Medical Laboratory Technology › Clinical Laboratory Practices and Quality Control
- Life Sciences › Neuroscience › Behavioral Neuroscience › Stress Responses and Cortisol
- Keywords
- adrenal insufficiency, ACTH stimulation test, monoclonal antibody assay, false positives, baseline cortisol
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
The claim verdicts this report counts are experimental: their accuracy is not yet measured.
A language model drew the claims from the paper on 2026-10-07, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).
A second model labelled each claim on 2026-10-07 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).
Cited sources are checked with a language model’s help (gpt-6-sol).
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.